Is day-case surgery feasible for laser endoscopic enucleation of the prostate? A systematic review.

"Declarations Conflict of interestA. Miernik receives research funds of the German Federal Ministry of Education and Research, Berlin (D). He receives support for his travel activities from the European Society of Urology, Arnhem (NL) and the German Society of Urology, Düsseldorf (D). Furthermore, A. Miernik is consulted for KLS Martin, Tuttlingen (D), Avateramedical, Jena (D), LISA LaserProducts GmbH, Katlenburg-Lindau (D), Schoelly fiberoptics GmbH, Denzlingen (D), Dornier MedTech Laser GmbH (D), Medi-Tate Ltd. (IL, USA) and B. Braun New Ventures GmbH, Freiburg (D). A. Miernik is a speaker for the companies Richard Wolf GmbH (D) and Boston Scientific (USA). Additionally, he performed expert activities for the Ludwig Boltzmann Gesellschaft, Wien (A). A. Miernik is involved in numerous patents and inventions in the field of medical technology. C. Gratzke is an advisor for Astellas Pharma GmbH, Munich (D), Ipsen Pharma GmbH, Munich (D), Steba Biotech S.A., Luxembourg (LUX), Bayer Pharma, Leverkusen (D), Olympus Winter & Ibe GmbH, Hamburg (D), Medi-Tate Ltd., Or Akiva (IL), MSD, Haar (D), Astra- Zeneca, Cambridge (UK) and Roche, Basel (CH). C. Gratzke receives speaker fees from Amgen, California (USA), Astellas Pharma GmbH, Munich (D), Ipsen Pharma GmbH, Munich (D), Janssen-Cilag GmbH, Neuss (D), Bayer Pharma, Leverkusen (D), Takeda Pharmaceuticals, Tokio (JPN) and medac GmbH, Wedel (D). S. Tonyali has received a grant from European Urology Scholarship Programme. M.Y., M.K., M.E.P., M.E.S., H.C.A., T.T. and L.T. declare to have no conflicts of interest. Ethical approvalAs this is a systematic review of the literature, no ethics approval was necessary. Consent to participate (include appropriate statements)Not applicable for this section. Consent for publicationNot applicable for this section. Conflict of interest A. Miernik receives research funds of the German Federal Ministry of Education and Research, Berlin (D). He receives support for his travel activities from the European Society of Urology, Arnhem (NL) and the German Society of Urology, Düsseldorf (D). Furthermore, A. Miernik is consulted for KLS Martin, Tuttlingen (D), Avateramedical, Jena (D), LISA LaserProducts GmbH, Katlenburg-Lindau (D), Schoelly fiberoptics GmbH, Denzlingen (D), Dornier MedTech Laser GmbH (D), Medi-Tate Ltd. (IL, USA) and B. Braun New Ventures GmbH, Freiburg (D). A. Miernik is a speaker for the companies Richard Wolf GmbH (D) and Boston Scientific (USA). Additionally, he performed expert activities for the Ludwig Boltzmann Gesellschaft, Wien (A). A. Miernik is involved in numerous patents and inventions in the field of medical technology. C. Gratzke is an advisor for Astellas Pharma GmbH, Munich (D), Ipsen Pharma GmbH, Munich (D), Steba Biotech S.A., Luxembourg (LUX), Bayer Pharma, Leverkusen (D), Olympus Winter & Ibe GmbH, Hamburg (D), Medi-Tate Ltd., Or Akiva (IL), MSD, Haar (D), Astra- Zeneca, Cambridge (UK) and Roche, Basel (CH). C. Gratzke receives speaker fees from Amgen, California (USA), Astellas Pharma GmbH, Munich (D), Ipsen Pharma GmbH, Munich (D), Janssen-Cilag GmbH, Neuss (D), Bayer Pharma, Leverkusen (D), Takeda Pharmaceuticals, Tokio (JPN) and medac GmbH, Wedel (D). S. Tonyali has received a grant from European Urology Scholarship Programme. M.Y., M.K., M.E.P., M.E.S., H.C.A., T.T. and L.T. declare to have no conflicts of interest."

"Funding Open Access funding enabled and organized by Projekt DEAL."